Tilvestamab, a novel clinical stage humanized anti-AXL function blocking antibody

M. Blø, L. Hodneland Nilsson, A. Jackson, A. Boniecka, J. E. Toombs, L. Ahmed, P. M. Mydel, H. P. Marti, R. A. Brekken, H. Gabra, J. B. Lorens, D. R. Micklem, G. Gausdal

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S44
JournalEuropean Journal of Cancer
Volume138
DOIs
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this